Allergies News and Research

Latest Allergies News and Research

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

Over the past few months, doctors resorted to repurposing medicines that have already been approved for other diseases to treat coronavirus patients. One drug that was widely used in the pandemic, hydroxychloroquine, has been found to be ineffective in treating the viral infection.

11 May 2020

New diagnostic approach has potential to enhance infectious diseases surveillance

A new technique could provide vital information about a community's immunity to infectious diseases including malaria and COVID-19.

11 May 2020

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

11 May 2020

Common allergy medicine may improve survival in patients with malignant melanoma

Can a very common allergy medicine improve survival among patients suffering from the serious skin cancer, malignant melanoma? A new study from Lund University in Sweden indicates that this may be the case.

11 May 2020

New high-yield method for efficient production of birch pollen allergen for Immunotherapy

Allergies can significantly affect health and quality of life. While allergen immunotherapy provides long-lasting therapeutic relief to people suffering from environmental allergies, the therapy can last several years and requires large amounts of allergen.

11 May 2020

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

As the world grapples with the coronavirus disease (COVID-19), scientists race to develop treatments and vaccines to combat the viral infection. Though many ongoing trials show promise in fighting the novel coronavirus, Italian researchers claim they have developed a vaccine that can neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal cells.

10 May 2020

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.

8 May 2020

Study shows how air pollution makes COVID-19 mortality worse for marginalized populations

As scientists worldwide race to gather data about the novel coronavirus, one of the more surprising findings has been detecting the virus attached to fine particles of air pollution.

8 May 2020

The nutritional key to control autoimmunity and cancer

Scientists at the Department of Infection and Immunity of the Luxembourg Institute of Health revealed a novel mechanism through which the immune system can control autoimmunity and cancer.

8 May 2020

Most COVID-19 patients lose sense of smell by the third day, shows study

A University of Cincinnati researcher says a study of COVID-19 patients shows loss of the sense of smell is most likely to occur by the third day of infection with the novel virus. Most of these patients are also experiencing a loss of the sense of taste.

8 May 2020

Severe blood clotting and high bleeding risk identified in critically ill COVID-19 patients

Emerging data is pointing to a faulty blood clotting system in the most critically ill COVID-19 patients. Patients with underlying health problems are presenting a severe risk of VTE (blood clotting) – previously an unknown risk factor – as well as an increased bleed risk.

7 May 2020

Cytokine storms created by COVID-19 could be reduced by using blood filter

Cytokine storms created by COVID-19 are causing major organ destruction and death, and for the first time in the United States, when patients begin to show signs of trouble, physicians are replacing the usual filter in a kidney dialysis machine with a filter known to trap these tiny proteins, with the goal of avoiding the devastation.

6 May 2020

Allergic reactions can occur without being triggered by an allergen, finds study

Allergic reactions can occur without being triggered by an allergen such as grass or birch pollen - it is enough for the patient to be back in the same place in which he or she was previously exposed to the allergen, as researchers at the University of Tübingen have found.

5 May 2020

Allergies News and Research

Latest Allergies News and Research

Hydroxychloroquine is not effective against COVID-19, extensive U.S. study shows

New diagnostic approach has potential to enhance infectious diseases surveillance

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Common allergy medicine may improve survival in patients with malignant melanoma

New high-yield method for efficient production of birch pollen allergen for Immunotherapy

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

Study shows how air pollution makes COVID-19 mortality worse for marginalized populations

The nutritional key to control autoimmunity and cancer

Most COVID-19 patients lose sense of smell by the third day, shows study

Severe blood clotting and high bleeding risk identified in critically ill COVID-19 patients

Cytokine storms created by COVID-19 could be reduced by using blood filter

Allergic reactions can occur without being triggered by an allergen, finds study

Study finds two FDA-approved drugs are promising against COVID-19

Patients recently recovered from COVID-19 produce virus-specific antibodies

Researchers examine role of immune response in COVID-19 patients

Antibody produced by llamas shows promise against SARS-CoV-2

Nasal biomarkers correlated with pollen-specific allergy symptoms

Venatorx and GARDP collaborate to accelerate development of new antibiotic

Gene defects associated with eczema, wheeze, and nasal blockage during infancy

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in